EN DE
Watch PT Murni Sadar Tbk for free: we tell you when fair value or trend changes.
Data-driven stock valuation

PT Murni Sadar Tbk (MTMH) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of PT Murni Sadar Tbk stock IDR 464, price IDR 845, that is 45.1% below the price, quality 46 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare ID

PM PT Murni Sadar Tbk logo Thin data Nov 8, 2026

PT Murni Sadar Tbk

MTMH · JK
Very expensive, weak quality

Our calculation puts a fair price 45% below what the stock costs today.

Low debt
Last quarter vs. a year ago: revenue +23%, profit +36%.
Quality 46/100
Expensive Growth (revenue 5y +19.0 %/yr in IDR)
Thin margins · 3.2% net margin (TTM)
0.3% dividend yield · Token dividend
Fair value 463.97 IDR · Strongly overvalued
Negative free cash flow
Trails peers (5/13)
Narrow moat 35/100 · thin data
Thin data
⚠ Thinly traded
Watch PT Murni Sadar Tbk for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

2,723 IDR 800.00 IDR Fair Value 463.97 IDR Apr 2022 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.

How to read this chart

55‑month range 800.00 IDR – 2,723 IDR · fair‑value band 347.98 IDR – 585.68 IDR · the 845.00 IDR price screens above the 463.97 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.

Follow PT Murni Sadar Tbk in your weekly email

Every Wednesday you see whether PT Murni Sadar Tbk is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Murni Sadar Tbk, together with its subsidiaries, provides health services and manages private hospitals in Indonesia.

Show moreShow less

The company offers outpatient installation services, including specialist, family health, general, dental, tropical diseases, travel medicine, and pain clinics; laboratory services, such as clinical pathology, blood bank, biomolecular/PCR, microbiology, and anatomical pathology; radiotherapy, consists of LINAC, CT-simulator and immobilization, treatment planning system, and brachytherapy services.

It also provides radiology services, including general X-Ray, ultrasonography (USG), mammography, 128 slice CT scan, 1.5 Tesla MRI, and interventional radiology; heart & vascular center, such as ECG, treadmill test, echocardiology, holter monitoring, and cardiac catheterization laboratory; endoscopy, contain esophagoscopy, gastroscopy, colonoscopy, bronchoscopy, and ERCP; medical rehabilitation, comprising physiotherapy, speech and occupation therapy, and orthotic prosthetic.

In addition, the company offers general services, which includes emergency installation, and inpatient facility; intensive care; public facilities; operating theatres, ESWL, laporoscopic surgery, oncology, chemotherapy, pharmaceutical installations, medical checkup, lifestyle clinic, murni teguh IVF, home care, palliative care, EEG, EMG, and ambulance services; as well as operates IVF Centre.

Further, it provides general facilities such as, auditorium, cafeteria, commercials area, fitness gym, and homestay. PT Murni Sadar Tbk was founded in 2010 and is based in Medan, Indonesia.

Stock analysis

PT Murni Sadar Tbk (MTMH) currently trades at 845.00 IDR, while our model-based Fair Value estimate is 463.97 IDR, 45% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 558.78 IDR per share, and 3 of the 14 models we run sit above the 845.00 IDR price.

Bear case: the Economic Profit group reads lowest at 260.32 IDR, and 11 of the 14 models stay below the price. Data coverage for this calculation is low.

Scenario range: 347.98 IDR (bear) to 585.68 IDR (bull), the price of 845.00 IDR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

PT Murni Sadar Tbk reported revenue of 1.4T IDR in FY2025 versus 983B IDR in FY2021, a compound +8.4%/yr. Reported net income was 43.6B IDR in FY2025, compounding −23.9%/yr from FY2021.

Key figures

Market cap 1.7T IDR (≈ $97.1M) Micro · P/E ratio 36.3 · P/S ratio 1.14 · EPS (TTM) 23.28 IDR · Dividend yield 0.3% · Net margin 3.2% · Return on equity 3.2% · Return on assets (EBIT) 7.1% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).

What moves the price

The share trades about 39% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at −45%, MTMH screens richer than that median.

Fair Value models

Bear 347.98 IDR Fair Value 463.97 IDR Bull 585.68 IDR
Price 845.00 IDR · Downside -45.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (17.89 IDR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV 75.13 IDR 106.36 IDR 131.36 IDR 73
ROIC Compounder 75.13 IDR 106.36 IDR 131.36 IDR 72
Residual Income 401.59 IDR 414.27 IDR 450.45 IDR 71
All 14 models by family
Earnings-Based
Graham-Dodd 143.41 IDR 938.66 IDR 1,314 IDR 63
Lynch FV 273.26 IDR 390.37 IDR 507.48 IDR 61
PEG = 1.0 273.26 IDR 390.37 IDR 507.48 IDR 57
EPV 75.13 IDR 106.36 IDR 131.36 IDR 73
Multiples
P/E Multiple 347.98 IDR 463.97 IDR 579.96 IDR 63
P/S Multiple 268.89 IDR 358.52 IDR 448.15 IDR 58
P/B Multiple 2,399 IDR 3,198 IDR 3,998 IDR 55
EV/EBIT 353.16 IDR 591.28 IDR 829.40 IDR 64
EV/EBITDA 1,103 IDR 1,591 IDR 2,079 IDR 67
EV/Revenue 148.66 IDR 367.17 IDR 585.68 IDR 50
Asset-Based
NCAV (Graham) 355.35 IDR 476.16 IDR 710.69 IDR 54
Economic Profit
Residual Income 401.59 IDR 414.27 IDR 450.45 IDR 71
ROIC Compounder 75.13 IDR 106.36 IDR 131.36 IDR 72
Growth Earnings
Growth-Adj P/E 391.15 IDR 558.78 IDR 726.41 IDR 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 26
How much profit the company makes from its sales and capital
Quality Growth 72
Are margins and returns getting better?
Cashflow 42
Do the profits arrive as real cash?
Financial strength 40
Debt, balance sheet and risk of trouble
Investment 23
Does it invest with discipline instead of growing at any price?
Low Volatility 56
How calm the share price moves, does not count
Price momentum 22
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 4
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+27.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.0%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.8%
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−7.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−8.1%
Dividend (yield on the price)0.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.10% → 9%

MTMH screens overvalued: fair value 45% below the price. Compare with HCA Healthcare, Inc →

Compare PT Murni Sadar Tbk with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 234 stocks

Beats the industry median on 5/13 measures
Overall it trails its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −44.1% · Bottom 25%
Profitability
Return on equity (12 months) 3.2% · Below median
Return on assets 1.7% · Below median
Net margin (12 months) 3.2% · Below median
Operating margin (12 months) 12.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) 23.4% · Top 25%
Dividend yield (12 months) 0.3% · Bottom 25%
Balance sheet
Debt / equity 0.30× · Above median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (12 months) 36.3× · Priciest 25%
P/B 1.16× · Cheaper than median
P/S (12 months) 1.14× · Cheaper than median
EV/EBITDA 6.8× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 34
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)13 · sector 33
HEALTH (low debt)85 · sector 90
DIVIDEND (yield)6 · sector 39

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $23.40 $46.55 +99% vs MTMH
Aier Eye Hospital Group 300015 ¥9.01 ¥10.88 +21% vs MTMH
DaVita Inc DVA $191.35 $218.90 +14% vs MTMH
HCA Healthcare, Inc HCA $494.99 $547.34 +11% vs MTMH
Tenet Healthcare Corporation THC $283.33 $279.20 −1% vs MTMH
The Ensign Group ENSG $181.08 $140.09 −23% vs MTMH
Encompass Health Corporation EHC $137.54 $94.81 −31% vs MTMH
Fresenius SE FRE €52.48 €34.77 −34% vs MTMH
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,446 ₹5,234 −38% vs MTMH
Dr. Sulaiman Al Habib Medical Services Group 4013 215.00 SAR 109.45 SAR −49% vs MTMH

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

PT Murni Sadar Tbk: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "PT Murni Sadar Tbk Fair Value". https://www.fairvalue-calculator.com/stock/MTMH

Frequently asked questions

Is PT Murni Sadar Tbk (MTMH) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 463.97 IDR versus a price of 845.00 IDR, about 45% lower (overvalued).
What is the fair value of MTMH?
Our model-based fair value for PT Murni Sadar Tbk is 463.97 IDR (as of Nov 8, 2026), built from audited fundamentals. The current price: 845.00 IDR.
What is the quality score of MTMH?
PT Murni Sadar Tbk has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for PT Murni Sadar Tbk (MTMH)?
Our model-based price target is the fair value of 463.97 IDR (as of Nov 8, 2026) from 14 valuation models. Cautious scenario 347.98 IDR, optimistic scenario 585.68 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the PT Murni Sadar Tbk stock forecast for 2026?
Our models put fair value at 463.97 IDR, about 45% lower versus a price of 845.00 IDR (overvalued). Cautious scenario 347.98 IDR, optimistic scenario 585.68 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of PT Murni Sadar Tbk (MTMH)?
PT Murni Sadar Tbk reported trailing-twelve-month revenue of about 1.5T IDR (latest available figure, as of Nov 8, 2026).
Does PT Murni Sadar Tbk pay a dividend?
PT Murni Sadar Tbk currently shows a dividend yield of 0.29% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of PT Murni Sadar Tbk (MTMH) and when is the ex-dividend date?
PT Murni Sadar Tbk pays a dividend of 2.42 IDR per share a year, a dividend yield of 0.3%. The last ex-dividend date was Jun 24, 2026. The payout ratio is 10.4% of earnings. Our assessment: Token dividend. At a yield of 0.3% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.3% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of PT Murni Sadar Tbk (MTMH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For PT Murni Sadar Tbk it is 463.97 IDR per share (as of Nov 8, 2026), against a price of 845.00 IDR. It is the blended result of 14 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is PT Murni Sadar Tbk stock overvalued or undervalued in 2026?
As of Nov 8, 2026, MTMH trades above its calculated fair value: price 845.00 IDR, fair value 463.97 IDR, a gap of about −45% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MTMH?
No. The price is what the market pays today (845.00 IDR); the fair value is what the company's own numbers justify (463.97 IDR). For PT Murni Sadar Tbk the two are 381.03 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is PT Murni Sadar Tbk worth?
The market values PT Murni Sadar Tbk at about 1.7T IDR (market capitalisation, as of Nov 8, 2026). Per share that is 845.00 IDR; our models calculate a fair value of 463.97 IDR per share.
What do the bullish and bearish scenarios say about MTMH?
Our models span a range for PT Murni Sadar Tbk: cautious scenario 347.98 IDR, base 463.97 IDR, optimistic 585.68 IDR per share (as of Nov 8, 2026, price 845.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MTMH?
PT Murni Sadar Tbk trades at a price-to-earnings ratio of 36.3 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 463.97 IDR is built from several models across several years. Other multiples: P/B 1.2, P/S 1.1, EV/EBITDA 6.8.
How solid is the balance sheet of PT Murni Sadar Tbk (MTMH)?
Balance-sheet figures for PT Murni Sadar Tbk (as of Nov 8, 2026): return on equity 3.2%, debt of 0.30 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is MTMH from its 52-week high?
PT Murni Sadar Tbk trades at 845.00 IDR, about 39% below its 52-week high of 1,387 IDR and 6% above the low of 800.00 IDR (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 463.97 IDR is for.
Which stocks are comparable to PT Murni Sadar Tbk?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is PT Murni Sadar Tbk stock attractive at the current price?
The data as of Nov 8, 2026: price 845.00 IDR, calculated fair value 463.97 IDR (−45%), Quality Score 46/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MTMH calculated?
We run PT Murni Sadar Tbk through 14 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 463.97 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. PT Murni Sadar Tbk itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of PT Murni Sadar Tbk (MTMH)?
The closing price on Nov 9, 2026 was 845.00 IDR. Our model-based fair value is 463.97 IDR, about 45% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with PT Murni Sadar Tbk right now?
The price sits above even our optimistic bull case (585.68 IDR). The favourable scenario is already priced in. Weak quality (46/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of PT Murni Sadar Tbk

How large is the market capitalisation of PT Murni Sadar Tbk (MTMH)?
The market capitalisation of PT Murni Sadar Tbk is 1.7T IDR (≈ $97.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of PT Murni Sadar Tbk (MTMH)?
The price-to-sales ratio of PT Murni Sadar Tbk is 1.14 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of PT Murni Sadar Tbk (MTMH)?
Earnings per share at PT Murni Sadar Tbk are 23.28 IDR (price ÷ EPS = P/E 36.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of PT Murni Sadar Tbk (MTMH)?
The dividend yield of PT Murni Sadar Tbk is 0.3% (payout 10.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of PT Murni Sadar Tbk (MTMH)?
The net margin of PT Murni Sadar Tbk is 3.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of PT Murni Sadar Tbk (MTMH)?
The return on equity (ROE) of PT Murni Sadar Tbk is 3.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of PT Murni Sadar Tbk (MTMH)?
On an EBIT basis the return on assets of PT Murni Sadar Tbk is 7.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of PT Murni Sadar Tbk (MTMH)?
The operating margin of PT Murni Sadar Tbk is 12.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at PT Murni Sadar Tbk (MTMH)?
Revenue at PT Murni Sadar Tbk is growing +23.4% versus a year earlier (3y avg +18.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at PT Murni Sadar Tbk (MTMH)?
Earnings per share at PT Murni Sadar Tbk are growing +35.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does PT Murni Sadar Tbk (MTMH) generate?
The free cash flow of PT Murni Sadar Tbk is −94.7B IDR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does PT Murni Sadar Tbk (MTMH) carry?
The net debt of PT Murni Sadar Tbk is 747B IDR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch PT Murni Sadar Tbk in the live analysis

One click puts PT Murni Sadar Tbk on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.